Source: Eur Respir J 2009; 34: 1100-1110
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Dewachter L., Adnot S., Guignabert C., Tu L., Marcos E., Fadel E., Humbert M., Dartevelle P., Simonneau G., Naeije R., Eddahibi S.. Bone morphogenetic protein signalling in heritable versus idiopathic pulmonary hypertension. Eur Respir J 2009; 34: 1100-1110

Member's Comments

No comment yet.

Related content which might interest you: Targeting bone morphogenic protein receptor 2 (BMPR2) signalling to treat pulmonary arterial hypertension Source: Eur Respir J, 50 (3) 1701370; 10.1183/13993003.01370-2017 Year: 2017 Dysregulated bone morphogenetic protein signaling in pulmonary arterial hypertension Source: Annual Congress 2008 - Pathophysiology of pulmonary hypertension Year: 2008 Mutations in the bone morphogenic protein receptor 2 promoter in heritable pulmonary arterial hypertension Source: International Congress 2018 – Pathobiology of pulmonary hypertension Year: 2018 Pathobiology of pulmonary arterial hypertension Source: Eur Respir J 2002; 20: 1559-1572 Year: 2002 The microRNA cluster 17/92 regulates the expression of the bone morphogenetic protein receptor type II involved in the pathogenesis of pulmonary hypertension Source: Annual Congress 2009 - Pathobiology of pulmonary hypertension Year: 2009 The adverse effect of estrogen on bone morphogenetic protein receptor (BMPR) signal pathway in pulmonary arterial endothelial cells (PAEC) Source: Annual Congress 2009 - Pulmonary circulation II Year: 2009 Pathobiology of pulmonary arterial hypertension and right ventricular failure Source: Eur Respir J 2012; 40: 1555-1565 Year: 2012 Bone morphogenetic protein receptor-II as a regulator of pulmonary artery endothelial cell permeability: Relevance to the initiation and progression of heritable pulmonary arterial hypertension Source: Annual Congress 2010 - Pathobiology of pulmonary hypertension Year: 2010 Sphingosine-1-phosphate receptor 1 controls endothelial cells permeability and function through the Bone morphogenetic 9/Endoglin signaling pathway. Source: International Congress 2019 – Cellular responses and cell therapy in lung injury and repair Year: 2019 Involvement of FHL1 in vascular remodelling Source: Annual Congress 2006 - Lung vascular and parenchymal remodeling Year: 2006 The transforming growth factor-β/Smad2,3 signalling axis is impaired in experimental pulmonary hypertension Source: Eur Respir J 2007; 29: 1094-1104 Year: 2007 Oral presentation: The bone morphogenetic protein antagonist Gremlin in pulmonary hypertension Source: Lung Science Conference 2009 - Cell proliferation, Differentiation and Carcinogenesis Year: 2009 RhoA signalling influences cyclin D1 expression and associated fibroblast turnover: implications for idiopathic pulmonary fibrosis (IPF) Source: Annual Congress 2006 - Lung vascular and parenchymal remodeling Year: 2006 NMDA receptor crosstalk with PDGFR-β and BMPR2 is involved in smooth muscle cell proliferation in pulmonary arterial hypertension Source: International Congress 2016 – The nature of pulmonary hypertension Year: 2016 Genetics of pulmonary hypertension: from bench to bedside Source: Eur Respir J 2002; 20: 741-749 Year: 2002 BMPR2 mutations in pulmonary arterial hypertension with congenital heart disease Source: Eur Respir J 2004; 24: 371-374 Year: 2004 Pharmacological activation of Nur77 enhances BMP signalling and inhibits vascular remodelling in pulmonary arterial hypertension Source: International Congress 2018 – Pathobiology of pulmonary hypertension Year: 2018 Pulmonary vascular disease: an historical perspective Source: Eur Respir Mon 2012; 57: 1-16 Year: 2012 Bone morphogenetic proteins (BMPs) inhibit hypoxia stimulated human pulmonary artery fibroblast (PAF) proliferation via inhibition of p38 MAP kinase and HIF-1α Source: Annual Congress 2004 - Pathophysiology of pulmonary hypertension Year: 2004 Dickkopf proteins influence lung epithelial cell proliferation in idiopathic pulmonary fibrosis Source: Eur Respir J 2011; 37: 79-87 Year: 2011